Moreover, this research investigated how 3nAGN-NSC affected Mcl-1 expression and if suppressing Mcl-1 mRNA by siRNA to a particular target makes MCF-7 breast cancer cells more susceptible to 3nAG therapy via the apoptotic pathway induction. The gene discussed is MCL1; the disease is breast cancer.